Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.
about
Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complexNovel Strategies in the Prevention and Treatment of Urinary Tract InfectionsIntracellular Bacterial Communities: A Potential Etiology for Chronic Lower Urinary Tract SymptomsAdhesive fiber stratification in uropathogenic Escherichia coli biofilms unveils oxygen-mediated control of type 1 piliInflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic InfectionQuantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coliEarly severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infectionMorphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coliSmall-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled.Detection of intracellular bacterial communities in human urinary tract infection.Waging war against uropathogenic Escherichia coli: winning back the urinary tractSelective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens.Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis.Virulence plasmid harbored by uropathogenic Escherichia coli functions in acute stages of pathogenesis.Novel strategies to combat bacterial virulence.A murine model of urinary tract infection.PafR, a novel transcription regulator, is important for pathogenesis in uropathogenic Escherichia coli.Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors.Bacterial differentiation, development, and disease: mechanisms for survival.G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity.Uropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.Uroplakins in urothelial biology, function, and diseaseCommunity behavior and amyloid-associated phenotypes among a panel of uropathogenic E. coliEnterococcus faecalis subverts and invades the host urothelium in patients with chronic urinary tract infectionA survey on urinary tract infections associated with the three most common uropathogenic bacteria.The FimH Gene in Uropathogenic Escherichia coli Strains Isolated From Patients With Urinary Tract InfectionPopulation dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.Subinhibitory antibiotic therapy alters recurrent urinary tract infection pathogenesis through modulation of bacterial virulence and host immunityUrinary tract infection drives genome instability in uropathogenic Escherichia coli and necessitates translesion synthesis DNA polymerase IV for virulenceCongo Red Interactions with Curli-Producing E. coli and Native Curli Amyloid Fibers.Dimethyl sulfoxide and ethanol elicit increased amyloid biogenesis and amyloid-integrated biofilm formation in Escherichia coli.Establishment and Characterization of UTI and CAUTI in a Mouse Model.Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo.Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection.New paradigms of urinary tract infections: Implications for patient management.Distinguishing the contribution of type 1 pili from that of other QseB-misregulated factors when QseC is absent during urinary tract infection.Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children.Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli.YbcL of uropathogenic Escherichia coli suppresses transepithelial neutrophil migration.
P2860
Q24645503-C12A6BD6-6063-4571-B172-B72C8A41F905Q26772924-450312D0-9C52-4A36-9892-43270C968296Q26799248-74D52E03-0312-4CF0-AF4C-291906E7CB1FQ27321012-62CD181E-2316-48BF-8259-9A5EF5F755DDQ27728113-37224E85-5ED3-4E84-AC22-3E9D77437EC8Q28474780-4A592E41-F096-46FD-B405-3F888AD61F4BQ28475353-FAA85CB5-C9CB-4593-8D59-E0C9E5163940Q30499366-D09770E1-5ED6-4032-B486-851C919F5E32Q30885749-E003178C-C8C7-4EE4-84B0-1BBD1EE06886Q33284734-ED99975A-FB69-4E9E-A062-7449151E2AB4Q33311340-5527189D-C161-4A95-864C-01B0C428B723Q33613902-03D5280B-50F4-4BA2-8A48-17A23A7BF7DEQ33622796-86D45F1D-D501-42F9-81B1-174B13DFDB39Q33675852-712047B2-AE2B-4680-A52F-A884191C62D0Q33769094-B82877FE-0E10-4AB5-9A8D-E9CB3638B6B7Q33811627-3F266703-5B18-4220-BE20-2FCAF2081632Q34236010-33816296-64DF-458D-B153-F5787C325836Q34298692-FF226074-DD98-42F0-BFD9-F9576CB6F186Q34415785-A669DB6B-E5BA-4F8D-87DE-0ADE70FA1E1CQ34490425-DE334AEA-F9E2-4A1B-A3F3-51F435ABC19EQ34562945-7C913ED8-58C3-4828-B0B0-10E45D2B919FQ34876396-76F1C952-EC75-49D0-9395-757D2E2EF4C6Q34973621-2F4EC0B0-FF78-4EF8-99EC-DE073F507E42Q35044837-2997AD28-608A-455F-BA28-FE1C8C874BEBQ35074374-23524126-48C9-46EB-B851-FF459AFEDCDCQ35146841-9DAD3B35-A4EB-4663-8FE4-E64CCC669CF7Q35225460-08A9848A-7E15-4C66-A5DD-FF9BC8FD96DBQ35273075-DF2DFBAE-C03F-40FA-A350-67D1CCBE8A0BQ35677483-D593A83B-5818-4AD3-A1EE-BDDC8660D912Q35693750-D7E44BA4-51B6-4DAF-A4CF-0EF52467FCE1Q35814646-692DFA19-B85E-461B-A5A3-C77E7286C826Q35941073-C5413CDC-03C7-4C78-A7FA-8D35FEDAA0D1Q35980554-2A90CCA5-76A5-4374-A615-589CF0333510Q36079542-2569B62B-7199-480D-815F-9D2D4BE5AAE0Q36154064-C6F654E4-1C7F-4679-A2AF-BEBFE9C4364DQ36181046-BC087A06-6E13-4235-853F-FE69A63EDF79Q36211104-26B7A82E-23EF-49E3-8B37-7AF1281405ADQ36293989-6BBDC97B-E0B6-4FB4-BFC0-B16B72C202F5Q36396848-B9C0F0A7-134E-4955-937D-B18CC3718982Q36396917-01890DD8-F5F9-44FE-BA93-78C42F5CCB46
P2860
Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Escherichia coli from urine of ...... bacterial community formation.
@ast
Escherichia coli from urine of ...... bacterial community formation.
@en
type
label
Escherichia coli from urine of ...... bacterial community formation.
@ast
Escherichia coli from urine of ...... bacterial community formation.
@en
prefLabel
Escherichia coli from urine of ...... bacterial community formation.
@ast
Escherichia coli from urine of ...... bacterial community formation.
@en
P2093
P2860
P356
P1476
Escherichia coli from urine of ...... bacterial community formation.
@en
P2093
Corinne K Garofalo
Joseph J Palermo
Steven M Martin
Thomas M Hooton
Walter E Stamm
P2860
P356
10.1128/IAI.01123-06
P407
P577
2006-10-30T00:00:00Z